2,6-diaminopurine has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Chen, T; He, XX; Lin, JS; Ye, BX | 1 |
1 other study(ies) available for 2,6-diaminopurine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, beta-LPA.
Topics: 2-Aminopurine; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Hepatitis B virus; Humans; Virus Replication | 2008 |